CHANGSHA, China, May 29, 2026 /PRNewswire/ -- Zoomlion is accelerating the global rollout of new energy and intelligent agricultural machinery, using major exhibitions in Turkey, South Africa, Thailand, Brazil, and China to showcase hybrid tractors, intelligent harvesters and crop-specific mechanization solutions aligned with agriculture's shift toward greener, smarter, and more mechanized operations.

Hybrid tractors emerged as the Company's key showcase products across multiple markets. The DV3504 and DQ2604 featured prominently in Turkey and South Africa which highlighted Zoomlion's push to position hybrid machinery as a practical solution for large-scale farming and lower fuel consumption. In Turkey, the tractors made their full debut at the Konya Agriculture Fair, where Zoomlion emphasized their performance in high-load applications such as deep tillage, supported by its self-developed MiDD distributed intelligent electric drive system and dynamic energy control technology. In South Africa, the DV3504 became a centerpiece of the Company's presentation at the Nampo show, which drew interest for its combination of power, intelligent operation and energy-saving performance.

Brazil marked another milestone, with Zoomlion making its first appearance at Agrishow and formally launching the DV3504 for the local market. The Company positioned the tractor around Brazil's green agriculture trend and the operating needs of large-scale soybean and corn farming, while also signaling further regional investment through its local subsidiary and manufacturing base.

Beyond tractors, Zoomlion is using localized solutions to address crop-specific mechanization needs. At AGRITECHNICA ASIA 2026 in Bangkok, the Company launched the C600 sugarcane combine harvester as part of a broader solution for Southeast Asia's sugarcane sector. Designed for Thailand's planting density and terrain, the C600 integrates harvesting, conveying, defoliation, and cleaning, while its Z-Pilot intelligent management system incorporates autonomous driving and intelligent scheduling technologies. Zoomlion also presented supporting tractors and implements to form a full-process sugarcane mechanization solution.

At the Xinjiang International Agricultural Machinery Expo, Zoomlion further underscored the role of intelligent new energy technologies in its upgrade strategy. The Company introduced nine hybrid products, including the DH7-6000, which it described as the world's first tandem hybrid grain combine harvester. According to Zoomlion, the machine delivers lower energy consumption and higher operating efficiency than conventional equipment.

Taken together, the exhibitions show how Zoomlion is linking hybrid and intelligent technology with more localized agricultural solutions, while continuing to advance its "high-end, international, new energy" strategy in global markets.

The Intelligent Driving 9.0 version powered by LI AUTO-W (02015.HK)'s self-developed Mahe M100 chip achieved a major upgrade compared with version 8.0, Xie Yan, Chief Technology Officer of LI AUTO-W (02015.HK), said. Version 9.0 is the first intelligent driving system fully running on the Group's in-house chip. It is ranked among the first tier in the highly competitive industry, though this marks only the beginning, the CTO said. The Group aims in 2H26 to benchmark its performance against Tesla, Inc. (TSLA.US) FSD Beta version 14.

On international expansion, President Ma Donghui said LI AUTO-W's globalisation strategy is progressing steadily. In overseas markets, the Group is adopting a phased expansion approach, flexibly choosing between establishing subsidiaries to develop dealer networks or appointing exclusive general distributors based on local market size and competitive landscape. It aims to leverage leading local partners to rapidly build an integrated service system covering sales, delivery and after-sales support.

Ma added that LI AUTO-W's brand and products continue to gain recognition in overseas markets. In the Middle East and Central Asia markets, the L-series extended-range models will serve as the main offerings, with official entry into these markets in 3Q26. In 2H26, the Group will also launch the all-electric I6 model in the European market. For right-hand-drive markets, a right-hand-drive version of the Mega will be introduced by the end of this year in core Asia-Pacific regions such as Hong Kong and Singapore.
~

AASTOCKS Financial News
Website: www.aastocks.com

LG Electronics announced the launch of a series of innovative automotive products built on Google technology, sending its shares up by as much as 27% today (29th).

LG Electronics said its new suite of solutions is based on the Android Automotive operating system, featuring a single-chip design capable of simultaneously controlling multiple displays of different sizes, distinguishing it from traditional in-vehicle systems.

The company noted that the solution helps automakers sharply reduce the cost of deploying multi-screen in-car systems.
~

AASTOCKS Financial News
Website: www.aastocks.com

Jensen Huang, Founder and CEO of NVIDIA Corporation (NVDA.US), will attend NVIDIA's annual AI developer conference, GTC Taipei 2026, in Taipei next week, and will visit South Korea after completing his main itinerary, report told.

Industry sources expected that Huang may discuss cooperation during his visit to South Korea in areas such as high-bandwidth memory (HBM), next-generation AI accelerators and wafer foundry services with major South Korean semiconductor companies including Samsung Electronics and SK Hynix.
~

AASTOCKS Financial News
Website: www.aastocks.com

深圳2026年5月29日 /美通社/ -- 全球領先的AI+機器人藥物研發平台企業晶泰科技（2228.HK）今日宣佈，與創新生物製藥公司 DoveTree Medicines Unus Inc. 的戰略合作取得重要進展，並收到第二筆付款。

自去年6月雙方達成總價值最高可達59.9億美元的合作協議以來，雙方協作持續取得顯著進展。此前5100萬美元首付款所涉管線的相關專利已全部轉讓至 DoveTree。其中一個臨床前候選分子（Pre-clinical candidate, PCC）已率先推進至臨床申請前準備（IND-enabling）研究階段。根據協議，晶泰科技已收到第二筆1900萬美元付款。雙方未來將圍繞既定重點方向進一步深化藥物發現合作，並持續加速項目從早期發現向臨床開發的轉化。

重塑靶向策略：從「不可成藥」到系統性干預

此次合作結合了 DoveTree 在靶點生物學與轉化醫學方面的專業能力，以及晶泰科技在計算與自動化賦能藥物發現方面的平台能力。

晶泰科技獨有的動態構象精準建模平台，以量子物理算法與AI多尺度分子模擬為雙重引擎，能夠超越晶體結構靜態「快照」的局限，在原子精度下模擬真實生理環境中靶點蛋白更完整的運動過程，實現構象機制洞察精度與效率的雙重躍升。

與此同時，晶泰科技融合量子物理、AI 以及自動化合成與測試能力的 AI 藥物研發平台，實現了分子虛擬篩選與物理合成之間的高效銜接，加速了分子設計與驗證之間的反饋閉環。根據動態構象模型提供的結構信息，晶泰科技已構建起用於命中化合物（Hit）篩選的蛋白複合物預測模型，實現高效的 AI 虛擬篩選。具有潛力的分子隨即由晶泰自研的  SureRXN 反應預測模型精確評估可合成性、預測合成路徑，再交由大規模自動化機器人實驗集群完成並行合成與活性測試，形成「設計—合成—測試—分析」（DMTA）的高通量迭代閉環。

這一體系可在2-3個月內完成3000-4000個全新分子的合成與測試，成功率穩定超過 80%。即便面對缺乏先驗數據的全新靶點，平台也能在短時間內積累起高質量的真實數據，持續驅動算法優化與分子進化。這種從機制研究到實驗交付的能力，有望推動過去難以觸達的「難成藥」靶點進入更具可預測性的臨床前開發軌道，並加速其轉化為具有臨床價值的項目資產。

強強聯合，雙向賦能

晶泰科技與 DoveTree 合作項目的快速推進，建立在雙方優勢能力的互補之上：DoveTree 在靶點生物學、轉化醫學以及治療模式創新方面具備深厚積累，而晶泰科技則通過 AI 與自動化技術提升分子發現的效率與規模化能力。

雙方優勢的結合，不僅能夠推動新藥研發項目從發現階段更快進入臨床開發，同時也聚焦於具有明確臨床轉化潛力、但傳統上難以成藥的重要靶點，從而更有效地滿足重大未滿足醫療需求。

根據合作協議，晶泰科技未來有資格獲得後續里程碑付款及銷售分成，使其 AI 平台的長期價值能夠伴隨項目推進而持續體現。

晶泰科技董事局主席溫書豪博士表示：「我們與 DoveTree 的合作正持續取得可驗證的成果。這不僅印證了我們技術路徑的優勢，也讓我們對後續管線的規模化推進充滿信心。晶泰科技已經在多個研發項目的實戰中跑通了從靶點到 PCC 的完整閉環，我們期待將這一模式系統性地拓展到更多高價值靶點上，為行業提供確定性更高的創新產出，不斷突破『可成藥』的邊界。」

DoveTree 創始人 Gregory Verdine 教授表示：「晶泰科技打造了一個令人印象深刻的平台，其能力建立在 AI、基於物理的分子設計以及自動化合成與優化的深度融合之上。這些一體化能力有望同時提升針對複雜生物靶點開展藥物發現的速度與質量。我們對目前合作取得的進展感到滿意，並期待推動更多項目邁向臨床開發階段。」

關於DoveTree Medicines

DoveTree 是一家創新生物製藥公司，專注於開發針對重大未滿足臨床需求疾病的首創新藥（first-in-class）療法。公司由科學家及企業家 Gregory Verdine 博士創立並領導，結合對生物學機制的深刻理解與先進人工智能技術，探索新型治療策略並加速變革性藥物的開發。DoveTree 以中國雲南特有的古老珍稀植物——珙桐（又稱「鴿子樹」）命名。公司致力於融合美國前沿研發創新能力與成熟醫藥市場，以及中國快速崛起的研發生態與創新管線資源，如同繁盛而美麗的「鴿子樹」一樣，為人類健康帶來新的希望。

關於晶泰科技

晶泰科技（"XtalPi Holdings Limited"，股份簡稱：晶泰控股，XTALPI，股票代碼：2228.HK）由三位麻省理工學院的物理學家於 2015 年創立，是一個基於量子物理、以人工智能賦能和機器人驅動的創新型研發平台。公司採用基於量子物理的第一性原理計算、人工智能、高性能雲計算以及可擴展及標準化的機器人自動化相結合的方式，為製藥及材料科學（包括農業技術、能源及新型化學品以及化妝品）等產業的全球和國內公司提供藥物及材料科學研發解決方案及服務。

Anthropic has raised USD65 billion in its latest funding round, reaching a post-money valuation of USD965 billion and surpassing rival OpenAI for the first time. The round was led by Altimeter Capital, Dragoneer, Greenoaks and Sequoia Capital. Each lead investor committed more than USD2 billion, Bloomberg reported, citing people with the knowledge of the matter.

Google also purportedly invested several billion US dollars in this round, part of its previously announced commitment to invest up to USD40 billion in Anthropic over time.

Anthropic said Amazon.com, Inc. (AMZN.US) also participated in the round with a USD5 billion investment, which was likewise part of an earlier commitment.

In addition, Micron Technology, Inc. (MU.US), Samsung Electronics and SK Hynix joined the financing, although specific amounts were not disclosed.

OpenAI completed a funding round in March with a valuation of USD852 billion. The company is expected to confidentially file for an IPO in the US within the coming days or weeks.
~

AASTOCKS Financial News
Website: www.aastocks.com

• First-quarter revenue totaled RMB 13.03 billion. Quarterly gross margin reached 20.6%.

• Overseas deliveries surpassed 6,000 units for the first time in April, targeting sustained monthly overseas deliveries above 10,000 units in Q4.

• The Ultra trim took over 80% of early GX orders, becoming one of the most popular choices in the premium segment market in China.

• In April, ADAS mileage penetration on VLA 2.0-equipped XPENG vehicles surpassed 50% for the first time. VLA 2.0 is currently under testing in Europe.

GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- XPENG, a leading Chinese AI-driven technology company, today announced its financial results for the first quarter of 2026.

Accelerating Physical AI Commercialization: VLA 2.0, Robotaxi and Humanoid Robotics in Full Swing

During the earnings call, He Xiaopeng, Chariman & CEO, detailed the company's ongoing transformation from an automotive manufacturer into a global leader in physical AI world.

• VLA 2.0: VLA 2.0, which saw its ADAS mileage penetration rate on XPENG vehicles exceed 50% for the first time in April, is now being tested in Europe.

• Robotaxi: XPENG GX fleet is already conducting L4 public-road testing in Guangzhou ahead of Robotaxi pilot operations in Q3. The GX's L4 full-redundancy hardware and dual Turing SoC‑based VLA model are decoupled from the vehicle platform, enabling deployment across the entire XPENG lineup, including the MONA series.

• Humanoid Robotics: XPENG has recently completed the proprietary development of the next-gen agile and low-cost dexterous hand. XPENG strives to mass-produce its IRON humanoid robots by year-end, with initial deployment in XPENG showrooms, followed by commercial deliveries in China and overseas next year.

Smart EV Business Drives Profitability, Overseas Markets Expect to Contribute Above 20% of Q2 Revenue

Mr. He emphasized that within the XPENG ecosystem, its smart EV business has already achieved profitability. Quarterly gross margin reached 20.6%. The rapid growth of the automotive segment has generated strong cash flow, supporting its R&D investment for physical AI.

In April, XPENG's single-month overseas deliveries surpassed 6,000 units for the first time. In Q1, XPENG also secured No.1 among emerging Chinese EV brands across Norway, Denmark, Portugal, Indonesia, Belgium and Ireland. Overseas markets expect to contribute above 20% of Q2 revenue.

Launched on May 20, the 6-seater flagship SUV XPENG GX is the ultimate culmination of XPENG's technology vision for the L4 era. Priced above RMB 350,000, the Ultra trim took over 80% of early GX orders, becoming one of China's most popular premium models.

In H2, XPENG plans to introduce four models globally, targeting sustained monthly overseas deliveries above 10,000 units in Q4 and more than doubling its full-year deliveries abroad.

Outlook: Mass Production of Physical AI Will Fuel Huge Returns

XPENG is advancing the mass production and global commercialization of three core physical AI applications—VLA 2.0, Robotaxi, and humanoid robots—as key pillars with strong potential for both commercial scale and capital returns. "According to XPENG's strategic roadmap, the B2B market is projected to thrive first, and international markets are ultimately expected to yield greater commercial returns than the domestic market", said He.

About XPENG

Founded in 2014, XPENG is a leading Chinese AI-driven mobility company that designs, develops, manufactures, and markets Smart EVs, catering to a growing base of tech-savvy consumers. With the rapid advancement of AI, XPENG aspires to become a global leader in AI mobility, with a mission to drive the Smart EV revolution through cutting-edge technology, shaping the future of mobility.

To enhance the customer experience, XPENG develops its full-stack advanced driver-assistance system (ADAS) technology and intelligent in-car operating system in-house, along with core vehicle systems such as the powertrain and electrical/electronic architecture (EEA). Headquartered in Guangzhou, China, XPENG also operates key offices in Beijing, Shanghai, Silicon Valley, and Munich. Its Smart EVs are primarily manufactured at its facilities in Zhaoqing and Guangzhou, Guangdong province.

XPENG is listed on the New York Stock Exchange (NYSE: XPEV) and Hong Kong Exchange (HKEX: 9868).

For more information, please visit https://www.xpeng.com/.

For Media Enquiries
PR Department
XPeng Inc.
E-mail: [email protected]

XIAMEN, China, May 28, 2026 /PRNewswire/ -- CATL's Xiamen Energy Storage Validation Research Institute (ESVL), the world's largest and most comprehensive one-stop testing and validation platform in the industry, officially commenced operations on May 28, marking a major step into the era of real-world validation for the industry.

Spanning 10 hectares and backed by an investment of roughly RMB 3 billion (about 440 million U.S. dollars), the proving ground is designed as an open and shared infrastructure accessible to all players in the global energy storage sector.

The Imperative for Real-World Validation

As energy storage scales rapidly as a core enabler of the global energy transition, the industry is facing a widening gap between installed capacity and real-world performance. Nearly one in five large-scale energy storage power stations worldwide are underperforming, while 46.5% of energy storage systems experience grid-connection delays of more than two months. With validation capabilities still largely limited to component and scenario testing, the industry increasingly needs a more credible station-level validation framework.

Real-world validated energy storage is built on the premise of the grid's most demanding operating conditions. It moves validation from component-level testing to full-system and station-level verification, covering safety, grid-support capability and long-term reliability before deployment.

"Scientific rigor is more critical than ever as energy storage enters the gigawatt era," said Dr. Wu Kai, Chief Scientist of CATL. "That means being honest about equipment performance, respectful of grid dynamics and disciplined in testing results — while raising industry quality standards to the station level and bringing validation forward to the pre-delivery stage. ESVL is designed to reflect that rigor, and to help usher in a more trusted and sustainable era of real-world validation."

"ESVL is open to the global energy storage industry and works with leading certification bodies, including TÜV SÜD, TÜV Rheinland, CGC and CSA, to provide one-test, multi-witness, globally recognized services," said Dr. Chen Xiaobo, Head of ESVL. "As energy storage increasingly becomes a critical infrastructure asset, ESVL's independent, traceable real-world validated data can help regulators make evidence-based decisions, insurers price risk more precisely and financial institutions assess energy storage as a more credible, bankable asset."

Five Core Laboratories Deliver Full-Scenario Validation

ESVL is built around five innovative laboratories and marks multiple global firsts.

Grid connection that mirrors real-world grids. The world's first station-level grid integration laboratory is equipped with a 35kV/100MVA grid simulator and a real-time simulator, 14 times larger than NREL's 13.8kV/7MVA platform, setting a new global benchmark for grid‑level testing. It can test more than 10 large-scale energy storage containers at the same time, simulate 1,000-node grid topologies, and cover a frequency range of 15 Hz to 60 Hz. It can also validate station-level grid-forming capability and multi-unit coordination under complex grid conditions, helping improve commissioning safety and shorten commissioning cycles.

High-voltage failures traced to the root cause. Covering 1kV to 500kV, the High-Voltage Safety Laboratory can help investigate the underlying mechanisms of fire and explosion under extreme high-voltage conditions, including lightning impulses, power-frequency and DC withstand voltage, and partial discharge testing. By identifying the safety boundaries of key components and full systems, it helps guide equipment design toward preventing fire and explosion.

Controlled combustion testing at scale. The Thermal Safety and Combustion Laboratory is the world's first large indoor combustion facility equipped with a 20MW calorimeter. With 100,000 cubic meters of indoor combustion space, it can carry out explosion testing on nine large energy storage containers at the same time. It provides critical data for assessing safety spacing, deployment planning and system iteration.

Reliability proven in extreme climates. Equipped with climate, environmental, salt spray, rain and sand chambers, the Environment Reliability Laboratory can verify full-system energy storage containers under extreme conditions ranging from -50°C to 100°C and simulated high-altitude pressure environments up to 7,200 meters. It helps validate long-term performance under desert heat, high-altitude low pressure, coastal salt spray and other harsh environments.

EMC testing under real operating conditions. The Electromagnetic Compatibility Laboratory is the world's only facility capable of accommodating a full 40-foot container, equipped with a 65-ton turntable and a 5MW power supply, and able to perform EMC testing in an anechoic chamber under real high-power charge and discharge conditions. By replicating real operating conditions, it helps identify electromagnetic interference risks before deployment and improve communication and control reliability.

CATL's Proven Record in Real-World Projects

CATL's leadership in real-world validated energy storage is rooted in years of operational experience. In 2016, the company began developing 100 MWh-class lithium-ion battery energy storage technology, which led to a breakthrough in long-life zero-degradation technology in 2020 and the deployment of a 30 MW/108 MWh energy storage station in Jinjiang, China.

Since then, CATL has expanded its energy storage footprint globally, including the Quinbrook project in Australia and a large solar-plus-storage project in North America that later secured refinancing at a lower interest rate. In 2025, CATL's energy storage battery sales reached 121 GWh, with a global market share of 30.4%, ranking No. 1 worldwide for five consecutive years.

By combining continuous technological innovation, proven long-term project performance, and robust system-level validation capabilities, CATL is defining a new trust framework for the global energy storage industry.

• Cash position^[i] was RMB42.09 billion (US$6.10 billion) as of March 31, 2026
• Quarterly total revenues were RMB13.03 billion, a 17.6% decrease year-over-year
• Quarterly gross margin was 20.6%, an increase of 5.0 percentage points over the same period of 2025
• Quarterly vehicle margin was 12.1%, an increase of 1.6 percentage points over the same period of 2025

GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading global AI mobility technology company, today announced its unaudited financial results for the three months ended March 31, 2026.

Operational and Financial Highlights for the Three Months Ended March 31, 2026

• Total deliveries of vehicles were 62,682 for the first quarter of 2026, representing a decrease of 33.3% from 94,008 in the corresponding period of 2025.

• XPENG's physical sales network had a total of 733 stores, covering 256 cities as of March 31, 2026.

• XPENG self-operated charging station network reached 3,455 stations, including 2,398 XPENG ultra-fast charging stations as of March 31, 2026.

• Total revenues were RMB13.03 billion (US$1.89 billion) for the first quarter of 2026, representing a decrease of 17.6% from the same period of 2025, and a decrease of 41.4% from the fourth quarter of 2025.

• Revenues from vehicle sales were RMB11.00 billion (US$1.59 billion) for the first quarter of 2026, representing a decrease of 23.5% from the same period of 2025, and a decrease of 42.3% from the fourth quarter of 2025.

• Gross margin was 20.6% for the first quarter of 2026, compared with 15.6% for the same period of 2025 and 21.3% for the fourth quarter of 2025.

• Vehicle margin, which is gross profit of vehicle sales as a percentage of vehicle sales revenue, was 12.1% for the first quarter of 2026, compared with 10.5% for the same period of 2025 and 13.0% for the fourth quarter of 2025.

• Net loss was RMB1.78 billion (US$0.26 billion) for the first quarter of 2026, compared with a loss of RMB0.66 billion for the same period of 2025 and a profit of RMB0.38 billion for the fourth quarter of 2025. Excluding share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, non-GAAP net loss was RMB1.69 billion (US$0.24 billion) for the first quarter of 2026, compared with a loss of RMB0.43 billion for the same period of 2025 and a profit of RMB0.51 billion for the fourth quarter of 2025.

• Net loss attributable to ordinary shareholders of XPENG was RMB1.78 billion (US$0.26 billion) for the first quarter of 2026, compared with a loss of RMB0.66 billion for the same period of 2025 and a profit of RMB0.38 billion for the fourth quarter of 2025. Excluding share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, non-GAAP net loss attributable to ordinary shareholders of XPENG was RMB1.69 billion (US$0.24 billion) for the first quarter of 2026, compared with a loss of RMB0.43 billion for the same period of 2025 and a profit of RMB0.51 billion for the fourth quarter of 2025.

• Basic and diluted net loss per American depositary share (ADS) were both RMB1.87 (US$0.27) and basic and diluted net loss per ordinary share were both RMB0.93 (US$0.14) for the first quarter of 2026. Each ADS represents two Class A ordinary shares.

• Non-GAAP basic and diluted net loss per ADS were both RMB1.76 (US$0.26), and non-GAAP basic and diluted net loss per ordinary share were both RMB0.88 (US$0.13) for the first quarter of 2026.

• Cash position was RMB42.09 billion (US$6.10 billion) as of March 31, 2026, compared with RMB47.66 billion as of December 31, 2025.

Management Commentary

"Kickstarted by the successful launch of the GX, XPENG will deliver four new models this year, positioning us for a robust sales growth trajectory," said Mr. Xiaopeng He, Chairman and CEO of XPENG. "This year, I am dedicated to leading our team to achieve the mass production of Robotaxis and humanoid robots. We are nurturing a global business ecosystem to transform physical AI technologies into new growth drivers for revenue and profit."

"For the first quarter of 2026, our gross margin surpassed 20%. Our in-house technological innovation and surging international revenue enabled us to remain resilient through the industry's seasonal slowdown," added Dr. Hongdi Brian Gu, Vice Chairman and Co-President of XPENG. "We will accelerate the mass adoption and commercialization of physical AI applications as a corporate strategic priority."

Recent Developments

Deliveries in April 2026

• Total deliveries were 31,011 vehicles in April 2026.
  
  
• As of April 30, 2026, year-to-date total deliveries were 93,693 vehicles.

Launch of XPENG GX

On May 20, 2026, XPENG launched the XPENG GX, its tech flagship SUV.

Unaudited Financial Results for the Three Months Ended March 31, 2026

Total revenues were RMB13.03 billion (US$1.89 billion) for the first quarter of 2026, representing a decrease of 17.6% from RMB15.81 billion for the same period of 2025 and a decrease of 41.4% from RMB22.25 billion for the fourth quarter of 2025.

Revenues from vehicle sales were RMB11.00 billion (US$1.59 billion) for the first quarter of 2026, representing a decrease of 23.5% from RMB14.37 billion for the same period of 2025, and a decrease of 42.3% from RMB19.07 billion for the fourth quarter of 2025. The year-over-year and quarter-over-quarter decreases were mainly attributable to lower vehicle deliveries.

Revenues from services and others were RMB2.03 billion (US$0.29 billion) for the first quarter of 2026, representing an increase of 41.2% from RMB1.44 billion for the same period of 2025 and a decrease of 36.1% from RMB3.18 billion for the fourth quarter of 2025. The year-over-year increase was primarily attributable to increased revenues from technical research and development services ("technical R&D services") and parts and accessories sales. The quarter-over-quarter decrease was primarily due to the reduction in technical R&D services revenues following a significant milestone catch-up in the prior quarter, as well as no revenue contribution from carbon credit trading in the current quarter.

Cost of sales was RMB10.35 billion (US$1.50 billion) for the first quarter of 2026, representing a decrease of 22.5% from RMB13.35 billion for the same period of 2025 and a decrease of 40.9% from RMB17.51 billion for the fourth quarter of 2025. The year-over-year and quarter-over-quarter decreases were mainly in line with vehicle deliveries as described above.

Gross margin was 20.6% for the first quarter of 2026, compared with 15.6% for the same period of 2025 and 21.3% for the fourth quarter of 2025.

Vehicle margin was 12.1% for the first quarter of 2026, compared with 10.5% for the same period of 2025 and 13.0% for the fourth quarter of 2025. The year-over-year increase was primarily attributable to the cost reduction and improvement in product mix of models. The quarter-over-quarter decrease was due to higher unit vehicle costs resulting from increased memory chip and battery related costs.

Services and others margin was 66.5% for the first quarter of 2026, compared with 66.4% for the same period of 2025 and 70.8% for the fourth quarter of 2025. The quarter-over-quarter decrease was due to a decreased share of the revenue from technical R&D services and parts and accessories sales within total services and other revenue.

Research and development expenses were RMB2.91 billion (US$0.42 billion) for the first quarter of 2026, representing an increase of 46.8% from RMB1.98 billion for the same period of 2025 and an increase of 1.1% from RMB2.87 billion for the fourth quarter of 2025. The year-over-year increase was mainly due to higher expenses related to the development of new vehicle models and AI-related technologies as the Company expanded its product portfolio to support future growth.

Selling, general and administrative expenses were RMB1.88 billion (US$0.27 billion) for the first quarter of 2026, representing a decrease of 3.2% from RMB1.95 billion for the same period of 2025 and a decrease of 32.5% from RMB2.79 billion for the fourth quarter of 2025. The year-over-year and quarter-over-quarter decreases were primarily due to the lower commission to the franchised stores.

Other income, net was RMB0.18 billion (US$0.03 billion) for the first quarter of 2026, representing a decrease of 66.5% from RMB0.54 billion for the same period of 2025 and a decrease of 78.3% from RMB0.84 billion for the fourth quarter of 2025. The year-over-year and quarter-over-quarter decreases were primarily due to the decrease in receipt of government subsidies.

Fair value (loss) gain on derivative liability relating to the contingent consideration was a gain of RMB0.05 billion (US$0.01 billion) for the first quarter of 2026, compared with a loss of RMB0.12 billion for the same period of 2025 and a gain of RMB0.04 billion for the fourth quarter of 2025. This non-cash (loss) gain resulted from the fair value change of the contingent consideration related to the acquisition of DiDi Global Inc. ("DiDi")'s smart auto business.

Loss from operations was RMB1.87 billion (US$0.27 billion) for the first quarter of 2026, compared with RMB1.04 billion for the same period of 2025 and RMB0.04 billion for the fourth quarter of 2025.

Non-GAAP loss from operations, which excludes share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, was RMB1.78 billion (US$0.26 billion) for the first quarter of 2026, compared with a loss of RMB0.80 billion for the same period of 2025 and a profit of RMB0.08 billion for the fourth quarter of 2025.

Net loss was RMB1.78 billion (US$0.26 billion) for the first quarter of 2026, compared with a loss of RMB0.66 billion for the same period of 2025 and a profit of RMB0.38 billion for the fourth quarter of 2025.

Non-GAAP net loss, which excludes share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, was RMB1.69 billion (US$0.24 billion) for the first quarter of 2026, compared with a loss of RMB0.43 billion for the same period of 2025 and a profit of RMB0.51 billion for the fourth quarter of 2025.

Net loss attributable to ordinary shareholders of XPENG was RMB1.78 billion (US$0.26 billion) for the first quarter of 2026, compared with a loss of RMB0.66 billion for the same period of 2025 and a profit of RMB0.38 billion for the fourth quarter of 2025.

Non-GAAP net loss attributable to ordinary shareholders of XPENG, which excludes share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, was RMB1.69 billion (US$0.24 billion) for the first quarter of 2026, compared with a loss of RMB0.43 billion for the same period of 2025 and a profit of RMB0.51 billion for the fourth quarter of 2025.

Basic and diluted net loss per ADS were both RMB1.87 (US$0.27) for the first quarter of 2026, compared with RMB0.70 basic and diluted net loss per ADS for the first quarter of 2025 and RMB0.40 basic and diluted net profit per ADS for the fourth quarter of 2025.

Non-GAAP basic and diluted net loss per ADS were both RMB1.76 (US$0.26) for the first quarter of 2026, compared with RMB0.45 non-GAAP basic and diluted net loss per ADS for the first quarter of 2025 and RMB0.53 and RMB0.52 non-GAAP basic and diluted net profit per ADS for the fourth quarter of 2025, respectively.

Balance Sheets

As of March 31, 2026, the Company had a cash position of RMB42.09 billion (US$6.10 billion), compared with RMB45.28 billion as of March 31, 2025 and RMB47.66 billion as of December 31, 2025.

Business Outlook

For the second quarter of 2026, the Company expects:

• Deliveries of vehicles to be between 100,000 and 106,000, representing a year-over-year change of approximately -3.08% to +2.73%, and a quarter-over-quarter increase of approximately 59.54% to 69.11%.

• Total revenues to be between RMB19.60 billion and RMB20.80 billion, representing a year-over-year increase of approximately 7.25% to 13.82%, and a quarter-over-quarter increase of approximately 50.38% to 59.59%.

The above outlook is based on the current market conditions and reflects the Company's preliminary estimates of market and operating conditions, and customer demand, which are all subject to change.

Conference Call

The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on May 28, 2026 (7:00 PM Beijing/Hong Kong Time on May 28, 2026).

For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration process and dial in 5 minutes prior to the scheduled call start time. Upon registration, each participant will receive dial-in details to join the conference call.

Event Title:               XPENG First Quarter 2026 Earnings Conference Call
Pre-registration link: https://s1.c-conf.com/diamondpass/10054534-c1s7jl.html  

Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.xiaopeng.com.

A replay of the conference call will be accessible approximately an hour after the conclusion of the call until June 4, 2026, by dialing the following telephone numbers:

About XPENG

XPENG is a leading Chinese Smart EV and NEV company that designs, develops, manufactures, and markets Smart EVs and NEVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to become a smart technology company trusted and loved by users worldwide. In order to optimize its customers' mobility experience, XPENG develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture. XPENG is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Shenzhen, Silicon Valley and San Diego. The Company's Smart EVs and NEVs are mainly manufactured at its plants in Zhaoqing and Guangzhou, Guangdong province. For more information, please visit https://www.xpeng.com/.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP measures, such as non-GAAP (loss) profit from operations, non-GAAP net (loss) profit, non-GAAP net (loss) profit attributable to ordinary shareholders, non-GAAP basic (loss) profit per ordinary share and non-GAAP basic (loss) profit per ADS, in evaluating its operating results and for financial and operational decision-making purposes. By excluding the impact of share-based compensation expenses and fair value loss (gain) on derivative liability relating to the contingent consideration, the Company believes that the non-GAAP financial measures help identify underlying trends in its business and enhance the overall understanding of the Company's past performance and future prospects. The Company also believes that the non-GAAP financial measures allow for greater visibility with respect to key metrics used by the Company's management in its financial and operational decision-making. The non-GAAP financial measures are not presented in accordance with U.S. GAAP and may be different from non-GAAP methods of accounting and reporting used by other companies. The non-GAAP financial measures have limitations as analytical tools and when assessing the Company's operating performance, investors should not consider them in isolation, or as a substitute for net (loss) profit or other consolidated statements of comprehensive (loss) profit data prepared in accordance with U.S. GAAP. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. The Company mitigates these limitations by reconciling the non-GAAP financial measures to the most comparable U.S. GAAP performance measures, all of which should be considered when evaluating the Company's performance.

For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliations of GAAP and non-GAAP Results" set forth in this announcement.

Exchange Rate Information

This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB6.8980 to US$1.00, the exchange rate on March 31, 2026, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred to could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about XPENG's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: XPENG's goal and strategies; XPENG's expansion plans; XPENG's future business development, financial condition and results of operations; the trends in, and size of, China's EV market; XPENG's expectations regarding demand for, and market acceptance of, its products and services; XPENG's expectations regarding its relationships with customers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in XPENG's filings with the United States Securities and Exchange Commission. All information provided in this announcement is as of the date of this announcement, and XPENG does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For Investor Enquiries
IR Department
XPeng Inc.
E-mail: [email protected]

Jenny Cai
Piacente Financial Communications
Tel: +1-212-481-2050 or +86-10-6508-0677
E-mail: [email protected]

For Media Enquiries
PR Department
XPeng Inc.
E-mail: [email protected]

美國馬裡蘭州羅克維爾市和中國蘇州2026年5月28日 /美通社/ -- 致力於在腫瘤等領域開發創新藥物的領先的生物醫藥企業——亞盛醫藥（納斯達克代碼：AAPG；香港聯交所代碼：6855）宣布，因公司已符合香港聯交所上市規則第8.05（3）條的市值/收益要求，日前已獲得香港聯交所批准，將於2026年6月1日起正式將「B」標記從股票代碼中移除。這一調整意味著亞盛醫藥在市值和收入等方面達到了更高標准，是公司發展歷程上的又一重大裡程碑。

亞盛醫藥於2019年10月28日通過18A規則在香港聯交所主板掛牌上市，後陸續納入深港通和滬港通股票名單。移除「B」標記被視為一家18A生物科技公司發展壯大的重要標志，意味著企業在市值和收入等方面達到更高標准，是對其創新實力、商業化能力及發展前景的綜合認可。基於兩款核心產品——耐立克^®和利生妥^®的主要商業化貢獻，亞盛醫藥的2025年年度收入達5.74億元人民幣。

亞盛醫藥董事長、CEO楊大俊博士表示：「此次成功摘『B』，是對亞盛醫藥商業化能力及市場表現的重要認可，也是公司全球創新實力的有力彰顯。作為一家在港股、美股雙重主要上市的全球性生物醫藥企業，我們將繼續聚焦患者未滿足需求，加速核心產品全球臨床開發，致力於成為血液腫瘤領域的全球領先者，為全球患者帶來更多獲益，並為股東和和社會創造更多價值。」

關於亞盛醫藥

亞盛醫藥（納斯達克代碼：AAPG；香港聯交所代碼：6855）是一家綜合性的全球生物醫藥企業，致力於研發、生產和商業化創新藥，以解決腫瘤領域全球患者尚未滿足的臨床需求。公司已建立豐富的創新藥產品管線，包括抑制Bcl-2和 MDM2-p53 等細胞凋亡通路關鍵蛋白的抑制劑、新一代針對癌症治療中出現的激酶突變體的抑制劑以及蛋白降解劑。

公司核心品種耐立克^®是中國首個獲批上市的第三代BCR-ABL抑制劑，已獲批用於治療伴有T315I突變的慢性髓細胞白血病慢性期（CML-CP）和加速期（CML-AP）患者，以及對一代和二代TKI耐藥和/或不耐受的CML-CP成年患者。該藥物所有獲批適應症均已被納入中國國家醫保藥品目錄（NRDL）。目前，亞盛醫藥正在開展耐立克^®三項全球注冊III期臨床研究，分別為：獲美國FDA和歐洲EMA許可的評估耐立克^®治療新診斷費城染色體陽性急性淋巴細胞白血病（Ph+ ALL）患者POLARIS-1研究；獲美國FDA和歐洲EMA許可的評估耐立克^®治療經治CML-CP成年患者的POLARIS-2研究；評估耐立克^®治療SDH-缺陷型GIST患者的POLARIS-3研究。

公司另一重磅品種利生妥^®是一款用於治療多種血液系統惡性腫瘤的新型Bcl-2抑制劑。利生妥^®已獲中國國家藥品監督管理局（NMPA）批准，用於治療既往至少接受過一種包括布魯頓酪氨酸激酶（BTK）抑制劑在內的系統治療的成人慢性淋巴細胞白血病/小淋巴細胞淋巴瘤（CLL/SLL）患者。目前，亞盛醫藥正在開展利生妥^®四項全球注冊III期臨床研究，分別為：獲美國FDA和歐洲MEA許可的評估利生妥^®聯合BTK抑制劑治療既往接受BTK抑制劑治療超過12個月且應答不佳的CLL/SLL患者的GLORA研究；評估利生妥^®一線治療初治CLL/SLL患者的GLORA-2研究；評估利生妥^®一線治療新診斷老年或不耐受的AML患者的GLORA-3研究；以及獲美國FDA和歐洲EMA許可的評估利生妥^®一線治療新診斷中高危MDS患者的GLORA-4研究。

憑借強大的研發能力，亞盛醫藥已在全球范圍內進行知識產權布局，並與武田、阿斯利康、默沙東、輝瑞、信達等眾多領先的生物制藥公司達成全球合作，同時與丹娜法伯癌症研究院、梅奧醫學中心、美國國家癌症研究所和密西根大學等學術機構建立研發合作關系。如需了解更多信息，請訪問 https://ascentage.com/

前瞻性聲明

本新聞稿包含根據美國《1995年私人證券訴訟改革法案》，以及經修訂的《1933年證券法》第27A條和《1934年證券交易法》第21E條所界定的前瞻性陳述。除歷史事實陳述外，本新聞稿中的所有內容均可能構成前瞻性陳述，包括亞盛醫藥對未來事件、經營成果或財務狀況所發表的意見、預期、信念、計劃、目標、假設或預測。

這些前瞻性陳述受到諸多風險和不確定性的影響，具體內容已在亞盛醫藥向美國證券交易委員會（SEC）提交的文件中詳細說明，包括2026年4月29日提交的20-F表格中截止2025年12月31日的年度報告中的「風險因素」和「關於前瞻性聲明的警示聲明」章節，2019年10月16日提交的首次發行上市招股書中的「前瞻性聲明」、「風險因素」章節，以及我們不時向SEC或HKEX提交的其他文件。這些因素可能導致實際業績、運營水平、經營成果或成就與前瞻性陳述中明示或暗示的信息存在重大差異。本前瞻性聲明中的陳述不構成公司管理層的利潤預測。

因此，該等前瞻性陳述不應被視為對未來事件的預測。本新聞稿中的前瞻性陳述僅基於亞盛醫藥當前對未來發展及其潛在影響的預期和判斷，且僅代表截至陳述發表之日的觀點。無論出現新信息、未來事件或其他情況，亞盛醫藥均無義務更新或修訂任何前瞻性陳述。